| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b75a05785dbfd86d27a87ddcdc5a524 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb00eda850058a6357e1f83da69f843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2cc87b838cc39d22502dcbf91f48e06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_318e315157df7c686f70816645f69a35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d535472d744147894740072796e7a372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af029cefb9271e1a34f117c1ea096a94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12fe330fc3a3685fce0a5eb2a4cbb5b4 |
| publicationDate |
2022-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114010758-A |
| titleOfInvention |
Application of AZD5582 in the preparation of drugs for the treatment of myelodysplastic syndromes |
| abstract |
The invention discloses the application of AZD5582 in the preparation of medicine for treating myelodysplastic syndrome. AZD5582 is used for the first time to treat the cell line of myelodysplastic syndrome, and AZD5582 significantly inhibits cell line proliferation and promotes and induces cell apoptosis at low dose. The invention provides an effective choice for clinical research and development of new drugs for treating myelodysplastic syndromes. |
| priorityDate |
2021-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |